Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Hazard Mater ; 403: 124000, 2021 02 05.
Artigo em Inglês | MEDLINE | ID: mdl-33265034

RESUMO

Diclofenac (DCF) is one of the most commonly utilized non-steroidal anti-inflammatory drugs (NSAIDs), which is known to pose an ecotoxicological threat. In this study, from activated sludge and contaminated soil, we isolated four new bacterial strains able to degrade DCF under mono-substrate and co-metabolic conditions with glucose supplementation. We found that the effectiveness of DCF removal is strictly strain-specific and the addition of the primary substrate is not always beneficial. To assess the multidirectional influence of DCF on bacterial cells we evaluated the alterations of increasing concentrations of this drug on membrane structure. A significant increase was observed in the content of 17:0 cyclo fatty acid, which is responsible for reduced fluidity and profound changes in membrane rigidity. The cell injury and oxidative stress were assessed with biomarkers used as endpoints of toxicity, i.e. catalase (CAT), superoxide dismutase (SOD), lipids peroxidation (LPX), and both intra- and extracellular alkaline and acid phosphatase activity. Results indicated that DCF induced oxidative stress, frequently intensified by the addition of glucose. However, the response of the microbial cells to the presence of DCF should not be generalized, since the overall picture of the particular alterations greatly varied for each of the examined strains.


Assuntos
Diclofenaco , Poluentes Químicos da Água , Anti-Inflamatórios não Esteroides/toxicidade , Diclofenaco/toxicidade , Peroxidação de Lipídeos , Estresse Oxidativo , Poluentes Químicos da Água/farmacologia
2.
Int J Mol Sci ; 21(18)2020 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-32947916

RESUMO

Diclofenac (DCF) constitutes one of the most significant ecopollutants detected in various environmental matrices. Biological clean-up technologies that rely on xenobiotics-degrading microorganisms are considered as a valuable alternative for chemical oxidation methods. Up to now, the knowledge about DCF multi-level influence on bacterial cells is fragmentary. In this study, we evaluate the degradation potential and impact of DCF on Pseudomonas moorei KB4 strain. In mono-substrate culture KB4 metabolized 0.5 mg L-1 of DCF, but supplementation with glucose (Glc) and sodium acetate (SA) increased degraded doses up to 1 mg L-1 within 12 days. For all established conditions, 4'-OH-DCF and DCF-lactam were identified. Gene expression analysis revealed the up-regulation of selected genes encoding biotransformation enzymes in the presence of DCF, in both mono-substrate and co-metabolic conditions. The multifactorial analysis of KB4 cell exposure to DCF showed a decrease in the zeta-potential with a simultaneous increase in the cell wall hydrophobicity. Magnified membrane permeability was coupled with the significant increase in the branched (19:0 anteiso) and cyclopropane (17:0 cyclo) fatty acid accompanied with reduced amounts of unsaturated ones. DCF injures the cells which is expressed by raised activities of acid and alkaline phosphatases as well as formation of lipids peroxidation products (LPX). The elevated activity of superoxide dismutase (SOD) and catalase (CAT) testified that DCF induced oxidative stress.


Assuntos
Anti-Inflamatórios não Esteroides/metabolismo , Proteínas de Bactérias/metabolismo , Diclofenaco/metabolismo , Pseudomonas/metabolismo , Poluentes Químicos da Água/metabolismo , Anti-Inflamatórios não Esteroides/farmacologia , Proteínas de Bactérias/genética , Biodegradação Ambiental , Biotransformação/genética , Catalase/genética , Catalase/metabolismo , Permeabilidade da Membrana Celular/efeitos dos fármacos , Meios de Cultura/farmacologia , Diclofenaco/farmacologia , Dioxigenases/genética , Dioxigenases/metabolismo , Indução Enzimática/efeitos dos fármacos , Ácidos Graxos/metabolismo , Regulação Bacteriana da Expressão Gênica/efeitos dos fármacos , Glucose/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Lipídeos de Membrana/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Pseudomonas/efeitos dos fármacos , Acetato de Sódio/farmacologia , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo , Poluentes Químicos da Água/farmacologia
3.
Int J Mol Sci ; 13(12): 16751-68, 2012 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-23222680

RESUMO

Statistical studies have demonstrated that various agents may reduce the risk of cancer's development. One of them is activity of flavin-dependent enzymes such as flavin-containing monooxygenase (FMO)(GS-OX1), FAD-dependent 5,10-methylenetetrahydrofolate reductase and flavin-dependent monoamine oxidase. In the last decade, many papers concerning their structure, reaction mechanism and role in the cancer prevention were published. In our work, we provide a more in-depth analysis of flavin-dependent enzymes and their contribution to the cancer prevention. We present the actual knowledge about the glucosinolate synthesized by flavin-containing monooxygenase (FMO)(GS-OX1) and its role in cancer prevention, discuss the influence of mutations in FAD-dependent 5,10-methylenetetrahydrofolate reductase on the cancer risk, and describe FAD as an important cofactor for the demethylation of histons. We also present our views on the role of riboflavin supplements in the prevention against cancer.


Assuntos
5,10-Metilenotetra-Hidrofolato Redutase (FADH2)/metabolismo , Monoaminoxidase/metabolismo , Proteínas de Neoplasias/metabolismo , Neoplasias/prevenção & controle , Riboflavina/uso terapêutico , Complexo Vitamínico B/uso terapêutico , Animais , Flavina-Adenina Dinucleotídeo/metabolismo , Humanos , Neoplasias/enzimologia , Neoplasias/patologia , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA